[CAS NO. 59-00-7] Xanthurenic Acid

Ships within

Stock

Price

Qty

Total

$0.00

Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis

request a quote

If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [59-00-7]

Catalog

SLK-S4774

Brand

Selleck

CAS

59-00-7

DESCRIPTION [59-00-7]

Overview

MDL	MFCD00006754
Molecular Weight	205.17
Molecular Formula	C10H7NO4
SMILES	OC=1C2=C(C(O)=CC(C(O)=O)=N2)C=CC1

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Concentration Volume Mass	1 mg	5 mg	10 mg
1 mM	4.8740 mL	24.3700 mL	48.7401 mL
5 mM	0.9748 mL	4.8740 mL	9.7480 mL
10 mM	0.4874 mL	2.4370 mL	4.8740 mL
50 mM	-	-	-

Description

Xanthurenic acid (xanthurenate, 8-Hydroxykynurenic acid, 4,8-Dihydroxyquinaldic acid), a molecule arising from tryptophan metabolism by transamination of 3-hydroxykynurenine, activates mGlu2/3 Metabotropic glutamate receptors (mGlu2 and mGlu3).

Targets

mGlu2 ^[1]

mGlu3 ^[1]

In vitro

Xanthurenic acid (XA) is considered as a putative neurotransmitter in the CNS, being stored in synaptic vesicles and released by membrane depolarization in a Ca2+-dependent fashion. It is known to inhibit vesicular glutamate transporters (VGLUTs). In heterologous expression systems, Xanthurenic acid could activate both mGlu2 and mGlu3 receptors with high potency, but has no activity on mGlu4 and mGlu7 receptors. Xanthurenic acid induces cell death associated with caspase-3, -8, and -9 activation, nuclear DNA cleavage, and cytochrome C release while not associated with cytoskeleton breakdown -- apoptosis induced by xanthurenic acid does not cause cytoskeleton depolymerization.

In vivo

Systemic administration of Xanthurenic acid in mice produces antipsychotic-like effects in the MK-801-induced model of hyperactivity and peripheral xanthurenic acid can cross the blood-brain barrier, influence the activity of brain regions that are involved in the pathophysiology of schizophrenia.

References

[1] Francesco Fazio, et al. Scientific Reports volume. 2015, 5: 17799.
[2] Malina HZ, et al. BMC Physiol. 2001, 1:7.

Synonyms

2-Quinolinecarboxylic acid, 4,8-dihydroxy-

Quinaldic acid, 4,8-dihydroxy-

4,8-Dihydroxy-2-quinolinecarboxylic acid

4,8-Dihydroxyquinaldic acid

Xanthurenic acid

Xanthuric acid

8-Hydroxykynurenic acid

NSC 401570